CCND1 and neuroblastoma: Based on these results, we conclude that the observed anti-proliferative effect of miR-193b in neuroblastoma is mediated, at least in part, through targeting both cyclin D1 and MYCN, two oncogenes with essential roles in neuroblastoma tumorigenesis and thereby attractive therapeutic targets.